A protein that impacts Alzheimer’s disease offers new opportunities for targeted treatments, although its cell-specific ...
News Medical on MSN12d
CD2AP and Alzheimer’s disease: A key regulator of neurodegeneration and potential therapeutic targetA comprehensive Thought Leaders Invited Review in Brain Medicine highlights the crucial role of CD2-associated protein (CD2AP ...
The Mirror US on MSN12d
Two common herbs could be key to treating Alzheimer'sThe build-up of proteins associated with Alzheimer's were reduced by a plant compound which also lowered inflammation and ...
diseases driven by synapse loss and dysfunction. Boost Neuroscience was spun out of the Stanford University lab of Dr. Thomas Südhof, MD. Dr. Südhof was awarded the 2013 Nobel Prize in ...
decreases synapse loss, and sustains memory and cognition in various Alzheimer's mouse models. The collaboration's ...
Noise exposure is one of the most significant causes of synapse loss between inner hair cells and auditory nerve fibers, leading to a decline in hearing sensitivity.
His team has begun experiments to test if the stimulatory impact of psychedelics on peripheral synapse formation has therapeutic potential to treat disorders such as hearing loss and neuropathies.
A new study has found that a compound that is derived from herbs - such as rosemary and sage - can help to reverse some of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback